Laura R. Magni1, Clarissa Ferrari2, Giuseppe Rossi1, Elena Staffieri2, Aldo Uberti2, Dario Lamonaca3, Ileana Boggian3, Silvia Merlin3, Giuseppe Primerano4, Alessandra Mombrini4, Roberto Poli5, Francesco M. Saviotti6, Maria T. Caldera6, Luciana Zanotti6, Roberta Rossi1
ABSTRACT
OBJECTIVE: To assess the effectiveness of a cognitive-behavioral therapy-based intervention (Superwellness Program) on weight gain compared with a treatment-as-usual (TAU) approach in patients treated with antipsychotics, and to evaluate the relationship between body mass index (BMI) variation and clinical variables. METHOD: Eighty-five patients treated with antipsychotics were allocated across two groups, experimental (n=59) and control (n=26). The Superwellness Program (experimental group) consisted of 32 twice-weekly 1-hour sessions, conducted by a psychologist and a nutritionist/nurse, concurrently with moderate food intake and moderate physical activity plans. Sociodemographic, clinical, and biological variables were collected at baseline, at the end of intervention (16 weeks), and after 6 months. RESULTS: BMI change from baseline differed significantly between the experimental and control groups, with a larger decrease in the experimental group (F = 5.5, p = 0.021). Duration of illness moderated the effect of treatment on BMI (p = 0.026). No significant (p = 0.499) effect of intervention during the follow-up period was found. Interestingly, the intervention indirectly induced a significant (p = 0.024) reduction in metabolic risk by reducing BMI. CONCLUSION: A cognitive-behavioral therapy-based intervention could be useful in reducing weight in a clinical population taking antipsychotics, with consequent benefit to physical and mental health.
Keywords: Antipsychotic; cognitive-behavioral therapy; obesity; weight gain
THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS LANGUAGE.